The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Xiang, Z.
Right arrow Articles by Ertl, H. C. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Xiang, Z.
Right arrow Articles by Ertl, H. C. J.
The Journal of Immunology, 2003, 171: 4287-4293.
Copyright © 2003 by The American Association of Immunologists

Mucosally Delivered E1-Deleted Adenoviral Vaccine Carriers Induce Transgene Product-Specific Antibody Responses in Neonatal Mice 1

Zhiquan Xiang*, Yan Li*, Guangping Gao{dagger}, James M. Wilson{dagger} and Hildegund C. J. Ertl2,*

* Wistar Institute and {dagger} University of Pennsylvania, Philadelphia, PA 19104

E1-deleted adenoviral vectors of the human serotype 5 (AdHu5) and the chimpanzee serotype 68 (AdC68) expressing the rabies virus glycoprotein (rab.gp) were tested for induction of transgene product-specific Abs upon intranasal or oral immunization of newborn mice. Both vectors induced Abs to rabies virus that could be detected in serum and from mucosal secretions. Serum rabies virus neutralizing Ab titers sufficed to protect neonatally vaccinated mice against a subsequent challenge with rabies virus. The efficacy of the AdHu5rab.gp vector given orally to newborn mice born to AdHu5 virus-immune dams was not impaired by maternally transferred Abs to the vaccine carrier.




This article has been cited by other articles:


Home page
 J. Virol.Home page
J.-R. Yu, S. Kim, J.-B. Lee, and J. Chang
Single Intranasal Immunization with Recombinant Adenovirus-Based Vaccine Induces Protective Immunity against Respiratory Syncytial Virus Infection
J. Virol., March 1, 2008; 82(5): 2350 - 2357.
[Abstract] [Full Text] [PDF]

Home page
 CVIHome page
F. R. Okamba, E. Moreau, K. Cheikh Saad Bouh, C. A. Gagnon, B. Massie, and M. Arella
Immune Responses Induced by Replication-Defective Adenovirus Expressing the C-Terminal Portion of the Mycoplasma hyopneumoniae P97 Adhesin
Clin. Vaccine Immunol., June 1, 2007; 14(6): 767 - 774.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
M. Hashimoto, J. L. Boyer, N. R. Hackett, J. M. Wilson, and R. G. Crystal
Induction of Protective Immunity to Anthrax Lethal Toxin with a Nonhuman Primate Adenovirus-Based Vaccine in the Presence of Preexisting Anti-Human Adenovirus Immunity
Infect. Immun., October 1, 2005; 73(10): 6885 - 6891.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
A. V. E. Capozzo, L. Cuberos, M. M. Levine, and M. F. Pasetti
Mucosally Delivered Salmonella Live Vector Vaccines Elicit Potent Immune Responses against a Foreign Antigen in Neonatal Mice Born to Naive and Immune Mothers
Infect. Immun., August 1, 2004; 72(8): 4637 - 4646.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2003 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2003 by The American Association of Immunologists, Inc. All rights reserved.